Christopher Miller
- Assistant Professor, Medical Imaging - (Clinical Scholar Track)
Contact
- (520) 626-1957
- Arizona Health Sciences Center, Rm. 1343
- Tucson, AZ 85724
- cmiller7@arizona.edu
Degrees
- M.D. Medicine
- Temple University School of Medicine, Philadelphia, Pennsylvania, United States
- M.S. Biomedical Informatics
- Arizona State University, Tempe, Arizona, United States
- B.S. Biology
- Arizona State University, Tempe, Arizona, United States
Work Experience
- Mayo Clinic (Arizona) (2018 - 2019)
- Banner University Medical Center (2014 - 2018)
- Tucson Hospitals Education Program (2013 - 2014)
Licensure & Certification
- Arizona Medical License, Arizona Medical Board (2018)
- Diagnostic Radiology Certificate, American Board of Radiology (2019)
Interests
No activities entered.
Courses
2024-25 Courses
-
Diagnostic Radiology
RADI 850A (Spring 2025) -
Diagnostic Radiology
RADI 850A (Fall 2024) -
Radiology
RADI 891A (Fall 2024)
2023-24 Courses
-
Independent Study
RADI 899 (Spring 2024) -
Diagnostic Radiology
RADI 850A (Fall 2023)
2020-21 Courses
-
Diagnostic Radiology
RADI 850A (Spring 2021)
Scholarly Contributions
Journals/Publications
- Miller, C., Rodriguez, E. A., Perez, R., Zhang, N., Lim, E. S., Schwartz, M. A., McGirr, A. J., Srinivasan, A., Hewitt, W., Silva, A. C., Rakela, J., & Vargas, H. E. (2020). Clinical Outcomes of Portosystemic Shunts on the Outcome of Liver Transplantation. Liver Transplantation, 26(5), 693-701. doi:10.1002/lt.25710
- Miller, C., Woodhead, G., Babiker, H. M., Borazanci, E. H., Subbiah, V., Diab, A., Hennemeyer, C., Shah, A. H., Hultsch, R., Murthy, R., Swann, S., Rahimian, S., Geib, J., & Catlett, M. (2018). Preliminary safety of deep/visceral (D/V) image guided (IG) intratumoral injection (ITI) of IMO-2125.. Journal of Clinical Oncology, 36(15_suppl), e15150-e15150. doi:10.1200/jco.2018.36.15_suppl.e15150
- Miller, C., Woodhead, G., Babiker, H. M., Hennemeyer, C., Shah, A. H., Miller, C., Woodhead, G., Babiker, H. M., Hennemeyer, C., & Shah, A. H. (2018). Right tumor, right time: Systematic methodology for fiducial marker placement to achieve reliable and reproducible image guided (IG) delivery of intratumoral immunotherapy into deep/visceral (D/V) lesions and target-lesion imaging follow-up.. Journal of Clinical Oncology, 36(15_suppl), e24137-e24137. doi:10.1200/jco.2018.36.15_suppl.e24137
